911 Shares in Humana Inc. (NYSE:HUM) Bought by Dynasty Wealth Management LLC

Dynasty Wealth Management LLC purchased a new position in shares of Humana Inc. (NYSE:HUM) in the 4th quarter, according to the company in its most recent filing with the SEC. The institutional investor purchased 911 shares of the insurance provider’s stock, valued at approximately $231,000.

Several other large investors also recently made changes to their positions in the stock. State Street Corp raised its position in shares of Humana by 1.0% in the third quarter. State Street Corp now owns 5,357,420 shares of the insurance provider’s stock valued at $1,701,582,000 after purchasing an additional 53,272 shares during the period. FMR LLC grew its stake in Humana by 23.4% in the 3rd quarter. FMR LLC now owns 3,388,859 shares of the insurance provider’s stock valued at $1,073,387,000 after buying an additional 643,291 shares during the last quarter. Pzena Investment Management LLC raised its holdings in Humana by 8.1% in the 3rd quarter. Pzena Investment Management LLC now owns 2,506,250 shares of the insurance provider’s stock worth $793,830,000 after acquiring an additional 187,903 shares during the period. Ontario Teachers Pension Plan Board lifted its position in Humana by 6.5% during the 3rd quarter. Ontario Teachers Pension Plan Board now owns 1,173,535 shares of the insurance provider’s stock worth $371,705,000 after acquiring an additional 71,910 shares during the last quarter. Finally, Sanders Capital LLC boosted its holdings in Humana by 1.0% during the third quarter. Sanders Capital LLC now owns 1,168,341 shares of the insurance provider’s stock valued at $370,060,000 after acquiring an additional 11,923 shares during the period. Institutional investors own 92.38% of the company’s stock.

Humana Stock Performance

Humana stock opened at $270.91 on Friday. The firm has a market capitalization of $32.68 billion, a P/E ratio of 27.23, a P/E/G ratio of 2.05 and a beta of 0.56. The stock has a fifty day moving average price of $271.11 and a two-hundred day moving average price of $287.34. Humana Inc. has a 52-week low of $213.31 and a 52-week high of $406.46. The company has a debt-to-equity ratio of 0.68, a current ratio of 1.76 and a quick ratio of 1.76.

Humana (NYSE:HUM) last announced its quarterly earnings results on Tuesday, February 11th. The insurance provider reported ($2.16) earnings per share (EPS) for the quarter, beating the consensus estimate of ($2.26) by $0.10. Humana had a net margin of 1.02% and a return on equity of 11.70%. As a group, analysts anticipate that Humana Inc. will post 16.47 EPS for the current fiscal year.

Humana Dividend Announcement

The firm also recently declared a quarterly dividend, which will be paid on Friday, April 25th. Investors of record on Friday, March 28th will be given a dividend of $0.885 per share. The ex-dividend date is Friday, March 28th. This represents a $3.54 dividend on an annualized basis and a yield of 1.31%. Humana’s dividend payout ratio (DPR) is presently 35.58%.

Insider Activity at Humana

In other Humana news, insider Timothy S. Huval sold 3,703 shares of the business’s stock in a transaction on Tuesday, December 31st. The stock was sold at an average price of $256.26, for a total value of $948,930.78. Following the transaction, the insider now owns 8,181 shares of the company’s stock, valued at approximately $2,096,463.06. The trade was a 31.16 % decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this hyperlink. Insiders own 0.32% of the company’s stock.

Wall Street Analysts Forecast Growth

Several research firms recently weighed in on HUM. Wells Fargo & Company cut their price objective on Humana from $387.00 to $290.00 and set an “overweight” rating for the company in a research report on Monday, November 4th. TD Cowen upped their price target on Humana from $261.00 to $268.00 and gave the stock a “hold” rating in a report on Monday, November 4th. Piper Sandler raised their price objective on shares of Humana from $270.00 to $288.00 and gave the stock a “neutral” rating in a research note on Wednesday, January 15th. Truist Financial upped their target price on shares of Humana from $260.00 to $290.00 and gave the company a “hold” rating in a research note on Monday, January 6th. Finally, StockNews.com upgraded shares of Humana from a “hold” rating to a “buy” rating in a research report on Tuesday. Nineteen equities research analysts have rated the stock with a hold rating and six have issued a buy rating to the stock. Based on data from MarketBeat.com, Humana has an average rating of “Hold” and a consensus price target of $285.68.

Humana Profile

Humana Inc, together with its subsidiaries, provides medical and specialty insurance products in the United States. It operates through two segments, Insurance and CenterWell. The company offers medical and supplemental benefit plans to individuals. It has a contract with Centers for Medicare and Medicaid Services to administer the Limited Income Newly Eligible Transition prescription drug plan program; and contracts with various states to provide Medicaid, dual eligible, and long-term support services benefits.